10x Genomics (TXG) Assets Average (2019 - 2026)

10x Genomics has disclosed Assets Average across 8 years of filings, most recently posting $1.0 billion for Q1 2026.

• Assets Average for Q1 2026 came in at $1.0 billion, up 12.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 12.9% YoY), and the FY2025 annual result was $980.0 million, up 4.05% from the prior year.
• Assets Average came in at $1.0 billion for Q1 2026 at 10x Genomics, down from $1.0 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.0 billion in Q4 2025 to a low of $911.0 million in Q1 2025.
• The 5-year median for Assets Average is $998.9 million (2022), against an average of $978.0 million.
• Across the five-year window, Assets Average retreated 7.58% in 2024 and grew 12.9% in 2026, its largest moves.
• 10x Genomics' Assets Average stood at $1.0 billion in 2022, then dropped by 5.51% to $956.8 million in 2023, then slipped by 2.99% to $928.2 million in 2024, then advanced by 11.44% to $1.0 billion in 2025, then retreated by 0.56% to $1.0 billion in 2026.
• The last three Assets Average figures came in at $1.0 billion (Q1 2026), $1.0 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.